4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-359636
Chief Legal Officer sold 14,212 shares at $24.50 ($348,194)
- Chief Legal Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tousignant Jennifer Chief Legal Officer | 2026-08-19 | Sale | −4,212 | $24.50 | $103,194 | 0 | D |
| Tousignant Jennifer Chief Legal Officer | 2026-08-19 | Option exercise | +10,000 | $14.41 | $144,100 | 10,000 | D |
| Tousignant Jennifer Chief Legal Officer | 2026-08-19 | Sale | −10,000 | $24.50 | $245,000 | 0 | D |
| Derivatives | |||||||
| Tousignant Jennifer Chief Legal Officer | 2026-08-19 | Option exercise · Stock Option (Right to Buy) | −10,000 | 114,072 | D | ||
| Open-market sales · 14,212 sh · avg $24.50 · $348,194 | |||||||
Loading xslF345X06/ownership.xml…